US2016068503A1PendingUtilityA1
(-)-epigallocatechin gallate derivatives for inhibiting proteasome
Assignee: UNIV HONG KONG POLYTECHNICPriority: Aug 19, 2004Filed: Sep 15, 2015Published: Mar 10, 2016
Est. expiryAug 19, 2024(expired)· nominal 20-yr term from priority
Inventors:Tak-Hang ChanWai-Har LamLarry Ming-Cheung ChowQing Ping DouDeborah Joyce KuhnAslamuzzaman KaziSheng Biao WanKristin R. Landis-Piwowar
A61P 35/00A61P 43/00A61P 35/02C07D 311/62Y02P20/582
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of reducing tumor cell growth, the method including administering an effective amount of a compound having the formula:
Claims
exact text as granted — not AI-modified1 . A method of manufacturing a medicament for treating hematological cancers, the method comprising forming a medicament comprising a compound having the formula:
wherein
R 5 is —H; and
wherein the formula satisfies one of the following conditions (1) to (4):
(1) each of R 11 , R 12 , R 13 , R 21 , R 22 , R 2 , R 3 , and R 4 is an acetate group;
(2) each of R 11 , R 12 , R 13 , R 21 , R 22 , and R 2 is an acetate group, and each of R 3 and R 4 is —H;
(3) each of R 11 , R 12 , R 13 , R 21 , R 22 is an acetate group, each of R 2 and R 4 is an acetate group, and R 3 is —H;
(4) each of R 11 , R 12 , R 13 , R 21 , R 22 , and R 3 is an acetate group, and each of R 2 and R 4 is —H.
2 . A method of manufacturing a medicament for treating hematological cancers, the method comprising forming a medicament comprising a compound having the formula:
wherein the formula satisfies one of conditions (1) to (3):
(1) R 1 is —H, R 2 is —OH, and each of R 3 and R 4 is —H;
(2) R 1 is —H, each of R 2 and R 4 is —H, and R 3 is —OH;
(3) R 1 is —H, each of R 2 and R 4 is —OH, and R 3 is —H.
3 . The method of claim 1 , wherein each of R 11 , R 12 , R 13 , R 21 , R 22 , R 2 , R 3 , R 4 is an acetate group.
4 . The method of claim 1 , wherein each of R 11 , R 12 , R 13 , R 21 , and R 22 is an acetate group, R 2 is an acetate group, and each of R 3 and R 4 is —H.
5 . The method of claim 1 , wherein each of R 11 , R 12 , R 13 , R 21 , R 22 , and R 3 is an acetate group, and each of R 2 and R 4 is —H.
6 . The method of claim 1 , wherein each of R 11 , R 12 , R 13 , R 21 , and R 22 is an acetate group, each of R 2 and R 4 is an acetate group, and R 3 is —H.
7 . The method of claim 2 , wherein the formula satisfies condition (1).
8 . The method of claim 2 , wherein the formula satisfies condition (2).
9 . The method of claim 2 , wherein the formula satisfies condition (3).
10 . A compound having the formula:
wherein
R 5 is —H; and
wherein the formula satisfies one of the following conditions (1) to (3):
(1) each of R 11 , R 12 , R 13 , R 21 , R 22 , and R 2 is an acetate group, and each of R 3 and R 4 is —H;
(2) each of R 11 , R 12 , R 13 , R 21 , R 22 is an acetate group, each of R 2 and R 4 is an acetate group, and R 3 is —H;
(3) each of R 11 , R 12 , R 13 , R 21 , R 22 , and R 3 is an acetate group, and each of R 2 and R 4 is —H.
11 . The compound of claim 10 , wherein each of R 11 , R 12 , R 13 , R 21 , and R 22 is an acetate group, R 2 is an acetate group, and each of R 3 and R 4 is —H.
12 . The compound of claim 10 , wherein each of R 11 , R 12 , R 13 , R 21 , R 22 , and R 3 is an acetate group, and each of R 2 and R 4 is —H.
13 . The compound of claim 10 , wherein each of R 11 , R 12 , R 13 , R 21 , and R 22 is an acetate group, each of R 2 and R 4 is an acetate group, and R 3 is —H.Join the waitlist — get patent alerts
Track US2016068503A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.